Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FPRR2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,245
Award facts
- Contract value 100% obligated
- $17,245.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc. on September 26, 2025, for the supply of Xtandi 40 mg capsules (120-count units). This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and no set-aside designation was applied. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its Park Ridge location. Xtandi is an oncology medication used in the treatment of prostate cancer, reflecting the contractor's specialization in supplying prescription pharmaceuticals to federal healthcare systems.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which carries a total contract value of $499,999,999 and remains valid through November 2026. This IDC framework enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense medical facilities worldwide. As the prime contractor, DMS Pharmaceutical Group has demonstrated consistent success in competing for federal pharmaceutical supply contracts and serves as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FPRR2?
SPE2DB25FPRR2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FPRR2 worth?
The government has obligated $17,245 on SPE2DB25FPRR2.
Is contract SPE2DB25FPRR2 an order under another contract?
Yes. SPE2DB25FPRR2 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRR2 competed?
The extent of competition for SPE2DB25FPRR2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award